Latest News

Hebei Yichen Industrial Group (SEHK:1596) has reported FY 2025 first half revenue of C¥477.1 million and basic EPS of C¥0.05, alongside trailing twelve month revenue of C¥1.7 billion and EPS of C¥0.32 that cap a return to profitability after earlier losses. Over the past three half year periods, revenue has ranged from C¥498.7 million in 2024 H1 to C¥592.0 million in 2024 H2 and C¥477.1 million in 2025 H1. Over the same periods, net income has moved from a loss of C¥42.2 million in 2024 H1 to...

We feel now is a pretty good time to analyse Prothena Corporation plc's ( NASDAQ:PRTA ) business as it appears the...

If you are wondering whether Compass Minerals International at around US$23.82 is still priced attractively after its recent run, the key question is how its current share price lines up against its fundamentals. The stock has returned 8.3% over the past week and 19.9% year to date. However, this sits alongside a 2.5% decline over the past month and longer term returns of 150.5% over 1 year, a 26.2% decline over 3 years, and a 60.4% decline over 5 years. Recent coverage has highlighted...

LCI Industries stock in focus after recent performance shifts LCI Industries (LCII) has drawn investor attention following mixed recent share performance, with a small gain over the past week contrasting with a loss over the past month and flat movement over the past 3 months. See our latest analysis for LCI Industries. Looking beyond the recent swings, the 1 year total shareholder return of 41.45% and 3 year total shareholder return of 31.07% point to momentum that contrasts with the weaker...

As European markets navigate heightened uncertainty amid geopolitical tensions and rising energy costs, the pan-European STOXX Europe 600 Index has seen a decline of 3.79%, with major indexes in Germany, Italy, France, and the UK also experiencing notable drops. In this environment of volatility and inflation concerns, investors might find it beneficial to focus on high-growth tech stocks that demonstrate resilience through innovation and adaptability to changing market dynamics.

We wouldn't blame Best Buy Co., Inc. ( NYSE:BBY ) shareholders if they were a little worried about the fact that Corie...

Celcuity (NasdaqCM:CELC) received FDA Priority Review for its New Drug Application for gedatolisib in advanced breast cancer. The Priority Review follows strong Phase 3 efficacy results from the VIKTORIA-1 trial in HR-positive, HER2-negative breast cancer. An additional Phase 3 readout for the PIK3CA mutant cohort is upcoming and could further influence treatment standards for this patient group. Celcuity focuses on targeted therapies for cancer, with gedatolisib as a key asset in its...

If you are wondering whether Centene's current share price offers value or just more volatility, it helps to break the story down into what the market has been pricing in and how that compares with fundamentals. The stock closed at US$33.56, with returns of a 5.7% decline over 7 days, a 20.8% decline over 30 days, a 19.7% decline year to date, a 44.3% decline over the last year, a 47.7% decline over 3 years and a 46.9% decline over 5 years. This history sets a very specific backdrop for any...

Krystal Biotech: Stock Performance Context Krystal Biotech (KRYS) has drawn investor attention after a recent pullback, with the stock showing a 1-day return of a 1.39% decline, a 1-month return of a 5.81% decline, and a 1-year return of 37.57%. See our latest analysis for Krystal Biotech. Recent trading has been choppy, with a 30 day share price return of a 5.81% decline contrasting with a 1 year total shareholder return of 37.56%. This indicates that earlier momentum has cooled in the short...

NextDecade Corporation ( NASDAQ:NEXT ) shareholders (or potential shareholders) will be happy to see that insider...

AM Best affirmed the credit ratings and outlook for OneMain Holdings’ insurance subsidiaries, reinforcing its view of their financial strength. The decision reflects AM Best’s current assessment of the subsidiaries’ balance sheet quality, risk management and operating performance. For investors watching OneMain Holdings (NYSE:OMF), this rating affirmation comes alongside a mixed share price record. The stock closed at $53.05, with a 4.0% gain over the past week offsetting a 3.9% decline...

If you are wondering whether Lamb Weston Holdings' current share price reflects its underlying value, this article walks through the key signals you can use to judge that for yourself. The stock most recently closed at US$40.83, with returns of 0.5% over 7 days, a 14.9% decline over 30 days, a 3.5% decline year to date and a 22.1% decline over 1 year, alongside a 57.8% decline over 3 years and a 42.9% decline over 5 years. These moves have kept Lamb Weston on the radar for investors looking...

Comstock Resources announced that its Western Haynesville operations in Texas were selected in March 2026 to host the Texas Natural Gas-Fired Power Generation Hub, a U.S.-Japan joint project to be built and operated by NextEra Energy under Japan’s very large US$550 billion investment commitment. This collaboration positions Comstock near the center of a major new demand source for Western Haynesville gas, potentially reshaping its role in U.S. energy infrastructure. We’ll now examine how...

If you are wondering whether Collegium Pharmaceutical's current share price reflects its real worth, this breakdown will help you see what the numbers are actually saying about value. The stock closed at US$33.42, with returns of 13.1% over 1 year and 37.1% over 3 years, but a 26.0% decline over 30 days and 26.6% decline year to date may have changed how investors think about its risk and reward profile. Recent coverage has focused on Collegium Pharmaceutical in the context of its share...

As global markets navigate a volatile landscape marked by geopolitical tensions, inflation concerns, and fluctuating energy prices, small-cap stocks have experienced varied impacts. The S&P 600 Index for small-cap stocks reflects this uncertainty with recent declines, yet these conditions can present unique opportunities for discerning investors seeking value in the market. Identifying promising small-cap companies often involves looking at strong fundamentals and insider buying trends that...

Amid a backdrop of heightened global uncertainty, with U.S. equity indexes experiencing declines due to geopolitical tensions and inflation concerns, the tech sector continues to capture investor interest for its potential high growth opportunities. In such volatile times, identifying tech stocks that demonstrate strong fundamentals and adaptability to market shifts can be crucial for navigating these challenging conditions.

Golar LNG (NasdaqGS:GLNG) has launched a formal review of options for the business, including a possible sale, merger, asset divestitures, or changes to its corporate structure. The company has appointed Goldman Sachs as financial advisor to support this process. The review aims to assess ways to accelerate growth initiatives and evaluate how the current structure supports long term objectives. For investors watching Golar LNG at a share price of $54.06, the timing of this review follows a...

In a week marked by heightened volatility due to geopolitical tensions and rising energy prices, global markets have faced significant challenges, with major indices like the Dow Jones Industrial Average and Nasdaq Composite experiencing notable declines. Amidst this uncertainty, investors often look for growth companies with strong insider ownership as these can signal confidence in the company's potential despite broader market fluctuations.

Paycom Software (NYSE:PAYC) has been named best software in multiple categories in G2’s Spring 2026 Grid Reports, based on customer reviews. The company was also recognized as a 2026 Platinum Employer on the inaugural Where You Work Matters List. Paycom is reportedly the only firm in its sector to receive the Platinum Employer distinction. Paycom focuses on HR and payroll software, so third party recognition of product quality and customer satisfaction can matter for buyers comparing...

As global markets navigate a landscape marked by geopolitical tensions, volatile oil prices, and persistent inflation concerns, investors are increasingly seeking stability through dividend stocks. In such uncertain times, stocks that offer consistent dividend payouts can provide a measure of income reliability and potential resilience against market fluctuations.

Wondering if ONE Gas at around US$85.79 is priced for opportunity or already fully valued? This article walks through the key signals that matter for you. The stock has delivered a 10.8% return year to date and 20.4% over the last year, which sits against a modest 0.5% move over the past month and a 0.4% decline over the last week. Recent coverage has focused on ONE Gas as a regulated gas utility, highlighting its role in providing essential services and the way investors often look to such...

Investors may be wondering whether Protagonist Therapeutics at around US$102 still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 0.5% over the last 7 days, 16.9% over the last 30 days, 17.2% year to date and 106.7% over the last year. This naturally raises questions about how much of the story is already reflected in the share price. Recent news flow around Protagonist Therapeutics has focused on its progress as a biotech name and how the...

Vulcan Energy Resources (ASX:VUL) has laid out its FY 2025 first half scorecard with revenue of €4.1 million and a basic EPS loss of €0.14, alongside a net loss of €30.7 million that keeps the business firmly in investment mode. The company has seen revenue move from €3.8 million in 1H 2024 to €7.6 million in 2H 2024 and then €4.1 million in 1H 2025, while basic EPS losses shifted from €0.11 in 1H 2024 to €0.12 in 2H 2024 and €0.14 in the latest half. This sets up a clear focus on how quickly...

Wondering if Hamilton Lane at around US$97.53 is starting to look interesting on value, or if the market is still pricing in too much optimism. The stock is down 3.4% over the past week, 4.1% over the past month and has fallen 28.6% year to date and 34.2% over the last year, even though the 3 year and 5 year returns sit at 43.7% and 16.9% respectively. Recent headlines have focused on Hamilton Lane's role in private markets and its position in the broader capital markets space. This helps...